StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies r&d expenses

Research and development expenses are spending on new products and technology.

AXIM Biotechnologies's R&D Expenses for the twelve months ending Jun 30, 2024 was $90.64K, down 29.6% year over year. For fiscal 2023 it was $125.50K, down 18.3% from the year before. The highest annual figure on record is $2.06M in fiscal 2018.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$125.50K-18.3%
FY2022Dec 31, 2022$153.70K-46.0%
FY2021Dec 31, 2021$284.87K-33.2%
FY2020Dec 31, 2020$426.71K–
FY2019Dec 31, 2019$0-100.0%
FY2018Dec 31, 2018$2.06M+52.0%
FY2017Dec 31, 2017$1.35M+474.3%
FY2016Dec 31, 2016$235.58K-58.8%
FY2015Dec 31, 2015$571.46K–
FY2014Dec 31, 2014$0–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024$4.06K-88.1%
Q1 FY2024Mar 31, 2024$15.50K-23.8%
Q4 FY2023Dec 31, 2023$36.37K-18.5%
Q3 FY2023Sep 30, 2023$34.71K+16.8%
Q2 FY2023Jun 30, 2023$34.07K-3.1%
Q1 FY2023Mar 31, 2023$20.34K-54.0%
Q4 FY2022Dec 31, 2022$44.61K-35.0%
Q3 FY2022Sep 30, 2022$29.72K-55.8%
Q2 FY2022Jun 30, 2022$35.17K-26.8%
Q1 FY2022Mar 31, 2022$44.19K-56.2%
Q4 FY2021Dec 31, 2021$68.59K-64.1%
Q3 FY2021Sep 30, 2021$67.26K-38.4%
Q2 FY2021Jun 30, 2021$48.07K-60.4%
Q1 FY2021Mar 31, 2021$100.95K–
Q4 FY2020Dec 31, 2020$191.28K–
Q3 FY2020Sep 30, 2020$109.14K–
Q2 FY2020Jun 30, 2020$121.44K–
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0-100.0%
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$532.68K-21.5%
Q4 FY2018Dec 31, 2018$354.19K-31.5%
Q3 FY2018Sep 30, 2018$350.59K-44.6%
Q2 FY2018Jun 30, 2018$672.74K+968.7%
Q1 FY2018Mar 31, 2018$678.66K+383.5%
Q4 FY2017Dec 31, 2017$516.98K+621.7%
Q3 FY2017Sep 30, 2017$632.67K+621.3%
Q2 FY2017Jun 30, 2017$62.95K+39.7%
Q1 FY2017Mar 31, 2017$140.37K+350.2%
Q4 FY2016Dec 31, 2016$71.63K+11.2%
Q3 FY2016Sep 30, 2016$87.72K-34.1%
Q2 FY2016Jun 30, 2016$45.05K-82.1%
Q1 FY2016Mar 31, 2016$31.18K-50.2%
Q4 FY2015Dec 31, 2015$64.44K–
Q3 FY2015Sep 30, 2015$133.09K–
Q2 FY2015Jun 30, 2015$251.03K–
Q1 FY2015Mar 31, 2015$62.67K–
Q4 FY2014Dec 31, 2014$0–
Q3 FY2014Sep 30, 2014$0–

More AXIM Biotechnologies figures

See a number that looks wrong?